Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Investment approach | Long-only |
| Index | MSCI USA Sector Neutral Quality |
| Investment focus | Actions, États-Unis, Fondamental/qualité |
| Fund size | EUR 248 m |
| Total expense ratio | 0,15% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Sustainability | Non |
| Fund currency | USD |
| Currency hedged | No |
| Inception/ Listing Date | 1 juin 2010 |
| Distribution policy | Distributing |
| Distribution frequency | Quarterly |
| Fund domicile | Irlande |
| Fund Provider | HSBC ETF |
| Eligible for PEA | No |
| Germany | 30% d’exonération partielle |
| Switzerland | ESTV Reporting |
| Austria | Meldefonds |
| UK | UK Reporting |
| Italy | 26,0% |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | HSBC Securities Services (Ireland) DAC |
| Investment Advisor | HSBC Global Asset Management (UK) Limited |
| Custodian Bank | HSBC Continental Europe |
| Revision Company | KPMG |
| Fiscal Year End | 30 décembre |
| Swiss representative | HSBC Global Asset Management (Switzerland) AG |
| Swiss paying agent | HSBC Private Bank (Suisse) SA |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty | HSBC Securities Services (Ireland) DAC |
| Microsoft Corp | 7.86% |
| Apple | 7.12% |
| NVIDIA Corp. | 6.62% |
| Meta Platforms | 4.78% |
| Lam Research | 3.89% |
| Eli Lilly & Co. | 3.67% |
| The TJX | 3.33% |
| Applied Materials, Inc. | 3.11% |
| Visa, Inc. | 3.09% |
| KLA Corp. | 2.62% |
| United States | 95.93% |
| Ireland | 1.61% |
| Switzerland | 1.20% |
| United Kingdom | 1.08% |
| Other | 0.18% |
| Technology | 50.74% |
| Finance | 12.04% |
| Consumer Non-Cyclicals | 9.45% |
| Healthcare | 9.40% |
| Other | 18.37% |
| Broker | Rating | Kosten beleggingsplan | Kosten brokeraccount | |
|---|---|---|---|---|
| | 0,00 € | 0,00 € | View offer* | |
| | 0,00 € | 0,00 € | View offer** | |
| | 0,00 € | 0,00 € | View offer* |
| YTD | +14,18% |
| 1 maand | -4,48% |
| 3 maanden | +1,21% |
| 6 maanden | +5,34% |
| 1 jaar | +17,75% |
| 3 jaar | +58,86% |
| 5 jaar | +59,16% |
| Since inception | +805,88% |
| 2025 | +0,85% |
| 2024 | +32,42% |
| 2023 | +22,23% |
| 2022 | -14,94% |
| Rendement actuel de distribution | 0,68% |
| Dividenden (laatste 12 maanden) | EUR 0,42 |
| Periode | Dividend in EUR | Dividendrendement in % |
|---|---|---|
| 1 an | EUR 0,42 | 0,80% |
| 2025 | EUR 0,55 | 1,01% |
| 2024 | EUR 0,43 | 1,03% |
| 2023 | EUR 0,41 | 1,19% |
| 2022 | EUR 0,37 | 0,89% |
| Risico-indicator |
Lager risico Hoger risico |
| Volatiliteit 1 jaar | 12,76% |
| Volatiliteit 3 jaar | 15,74% |
| Volatiliteit 5 jaar | 17,94% |
| Rendement / Risico 1 jaar | 1,39 |
| Rendement / Risico 3 jaar | 1,06 |
| Rendement / Risico 5 jaar | 0,54 |
| Maximaal waardedaling 1 jaar | -7,33% |
| Maximaal waardedaling 3 jaar | -23,00% |
| Maximaal waardedaling 5 jaar | -23,00% |
| Maximaal waardedaling sinds aanvang | -34,02% |
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | H4ZD | - - | - - | - |
| Euronext Paris | EUR | MUS | MUS FP HMUSEURI | MUS.PA HMUSINAVEUR=HSBL | Goldenberg Hehmeyer Societe Generale |
| London Stock Exchange | GBX | HMUS | |||
| London Stock Exchange | USD | HMUD | HMUD LN HMUSUSDI | HMUD.L HMUSINAVUSD=HSBL | Goldenberg Hehmeyer Societe Generale |
| London Stock Exchange | GBP | - | HMUS LN HMUSGBPI | HMUS.L HMUSINAVGBP=HSBL | Goldenberg Hehmeyer Societe Generale |
| SIX Swiss Exchange | USD | HMUS | HMUS SW HMUSUSDI | HMUS.S HMUSINAVUSD=HSBL | Goldenberg Hehmeyer Societe Generale |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Edge MSCI USA Quality Factor UCITS ETF USD (Dist) | 1,157 | 0.20% p.a. | Distributing | Full replication |